Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+9.55%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$46.1B
AUM Growth
-$3.1B
(-6.3%)
Cap. Flow
+$1.03B
Cap. Flow
% of AUM
2.23%
Top 10 Holdings %
Top 10 Hldgs %
25.33%
Holding
2,709
New
189
Increased
809
Reduced
1,156
Closed
275
Top Buys
| 1 |
Microsoft
MSFT
|
+$584M |
| 2 |
Apple
AAPL
|
+$407M |
| 3 |
NVIDIA
NVDA
|
+$311M |
| 4 |
Amazon
AMZN
|
+$299M |
| 5 |
Tesla
TSLA
|
+$182M |
Top Sells
| 1 |
Sempra
SRE
|
+$154M |
| 2 |
Energy Transfer Partners
ET
|
+$115M |
| 3 |
LTHM
Livent Corporation
LTHM
|
+$64.7M |
| 4 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$64M |
| 5 |
Intuitive Surgical
ISRG
|
+$58.9M |
Sector Composition
| 1 | Technology | 30.75% |
| 2 | Industrials | 10.18% |
| 3 | Consumer Discretionary | 8.58% |
| 4 | Communication Services | 7.35% |
| 5 | Energy | 7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Newell Brands
NWL
$2.56B
| $423K | ﹤0.01% |
+37,498
| New | +$423K |
|
1977
Sabesp
SBS
$16.1B
| $422K | ﹤0.01% |
25,073
-4,753
| -16% | -$80K |
|
1978
Cytek Biosciences
CTKB
$513M
| $421K | ﹤0.01% |
49,053
| – | – |
|
1979
CryoPort
CYRX
$494M
| $418K | ﹤0.01% |
19,468
| – | – |
|
1980
Comstock Resources
CRK
$4.63B
| $417K | ﹤0.01% |
39,071
-2,310
| -6% | -$24.7K |
|
1981
Photronics
PLAB
$1.33B
| $417K | ﹤0.01% |
26,355
-1,550
| -6% | -$24.5K |
|
1982
Chemours
CC
$2.5B
| $416K | ﹤0.01% |
15,830
-13,434
| -46% | -$353K |
|
|
INVX
1983
Innovex International, Inc.
INVX
$1.15B
| $416K | ﹤0.01% |
14,976
| – | – |
|
1984
TechTarget
TTGT
$419M
| $414K | ﹤0.01% |
11,786
| – | – |
|
1985
Talos Energy
TALO
$1.7B
| $413K | ﹤0.01% |
28,186
-22,541
| -44% | -$330K |
|
1986
Owens & Minor
OMI
$419M
| $413K | ﹤0.01% |
31,731
| – | – |
|
1987
The GEO Group
GEO
$3.25B
| $412K | ﹤0.01% |
52,803
| – | – |
|
1988
Integral Ad Science
IAS
$1.43B
| $411K | ﹤0.01% |
30,568
| – | – |
|
1989
CVR Energy
CVI
$3.21B
| $409K | ﹤0.01% |
12,664
-1,226
| -9% | -$39.6K |
|
1990
Treace Medical Concepts
TMCI
$467M
| $408K | ﹤0.01% |
16,277
-4,448
| -21% | -$111K |
|
1991
ProAssurance
PRA
$1.22B
| $408K | ﹤0.01% |
23,090
| – | – |
|
1992
Central Pacific Financial
CPF
$832M
| $407K | ﹤0.01% |
21,364
+5,954
| +39% | +$113K |
|
1993
IMAX
IMAX
$1.7B
| $404K | ﹤0.01% |
21,399
| – | – |
|
1994
Harmony Biosciences
HRMY
$1.93B
| $404K | ﹤0.01% |
12,952
-3,610
| -22% | -$112K |
|
1995
Ventyx Biosciences
VTYX
$170M
| $404K | ﹤0.01% |
+13,169
| New | +$404K |
|
|
AAT
1996
American Assets Trust
AAT
$1.27B
| $402K | ﹤0.01% |
22,571
-732
| -3% | -$13K |
|
|
ACCD
1997
DELISTED
Accolade, Inc. Common Stock
ACCD
| $402K | ﹤0.01% |
30,766
-19,695
| -39% | -$257K |
|
1998
Montrose Environmental
MEG
$1.07B
| $401K | ﹤0.01% |
11,833
-972
| -8% | -$33K |
|
1999
Oscar Health
OSCR
$5.05B
| $401K | ﹤0.01% |
71,519
-193,512
| -73% | -$1.09M |
|
2000
Collegium Pharmaceutical
COLL
$1.21B
| $400K | ﹤0.01% |
15,978
-735
| -4% | -$18.4K |
|